Compare IVVD & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | IMMR |
|---|---|---|
| Founded | 2020 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.9M | 215.8M |
| IPO Year | 2021 | 1999 |
| Metric | IVVD | IMMR |
|---|---|---|
| Price | $0.82 | $7.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $8.75 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 4.9M | 308.4K |
| Earning Date | 05-08-2026 | 04-13-2026 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $53,426,000.00 | $35,013,000.00 |
| Revenue This Year | $61.57 | N/A |
| Revenue Next Year | $41.42 | N/A |
| P/E Ratio | ★ N/A | $42.65 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.53 | $5.25 |
| 52 Week High | $3.07 | $8.05 |
| Indicator | IVVD | IMMR |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 45.38 |
| Support Level | $0.72 | $6.30 |
| Resistance Level | $1.02 | $7.76 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 28.19 | 36.04 |
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.